Fifth Third Bancorp’s Heron Therapeutics HRTX Stock Holding History

Fifth Third Bancorp’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.95K	Buy	+4,934	New	+$5.72K	﹤0.01%	3917
2022 Q1	–	Sell	-3,000	Closed	-$27K	–	2718
2021 Q4	$27K	Hold	3,000	–	–	﹤0.01%	1746
2021 Q3	$32K	Hold	3,000	–	–	﹤0.01%	1611
2021 Q2	$47K	Buy	+3,000	New	+$47.7K	﹤0.01%	1477
2020 Q3	–	Sell	-2,000	Closed	-$29K	–	2316
2020 Q2	$29K	Sell	2,000 -92	-4%	-$1.51K	﹤0.01%	1458
2020 Q1	$25K	Hold	2,092	–	–	﹤0.01%	1466
2019 Q4	$49K	Hold	2,092	–	–	﹤0.01%	1407
2019 Q3	$39K	Buy	2,092 +92	+5%	+$1.69K	﹤0.01%	1430
2019 Q2	$37K	Buy	2,000 +1,500	+300%	+$30K	﹤0.01%	1454
2019 Q1	$12K	Hold	500	–	–	﹤0.01%	1734
2018 Q4	$13K	Hold	500	–	–	﹤0.01%	1708
2018 Q3	$16K	Hold	500	–	–	﹤0.01%	1703
2018 Q2	$19K	Hold	500	–	–	﹤0.01%	1680
2018 Q1	$14K	Hold	500	–	–	﹤0.01%	1787
2017 Q4	$9K	Hold	500	–	–	﹤0.01%	1856
2017 Q3	$8K	Hold	500	–	–	﹤0.01%	1832
2017 Q2	$7K	Sell	500 -2,450	-83%	-$35.5K	﹤0.01%	1812
2017 Q1	$44K	Sell	2,950 -105	-3%	-$1.45K	﹤0.01%	1343
2016 Q4	$40K	Sell	3,055 -1,974	-39%	-$31K	﹤0.01%	1403
2016 Q3	$87K	Buy	5,029 +4,529	+906%	+$84K	﹤0.01%	1150
2016 Q2	$9K	Hold	500	–	–	﹤0.01%	1832
2016 Q1	$9K	Hold	500	–	–	﹤0.01%	1887
2015 Q4	$13K	Hold	500	–	–	﹤0.01%	1846
2015 Q3	$12K	Hold	500	–	–	﹤0.01%	1960
2015 Q2	$16K	Hold	500	–	–	﹤0.01%	1886
2015 Q1	$7K	Buy	+500	New	+$5.64K	﹤0.01%	2129

Other funds holding HRTX

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Fifth Third Bancorp's HRTX Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Heron Therapeutics (HRTX) in Q1 2026: 4,934 shares worth $3.95K. The stake represents ﹤0.01% of the portfolio and ranks #3917 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in HRTX as recently as Q4 2021.

Fifth Third Bancorp first reported a position in HRTX in Q1 2015 and has held it in 26 quarters since. The position peaked at $87K in Q3 2016. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

Fifth Third Bancorp held 4,934 shares of Heron Therapeutics worth $3.95K as of Q1 2026.
Heron Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
Heron Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3917 holding.
Fifth Third Bancorp first reported a position in Heron Therapeutics in Q1 2015 and has held it in 26 quarters since.
Fifth Third Bancorp's Heron Therapeutics position peaked at $87K in Q3 2016.
167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.